Rare Diseases

Latest News

5 Pending FDA Decisions in Neurology to Look for in 2023
5 Pending FDA Decisions in Neurology to Look for in 2023

January 27th 2023

Take a look at 5 of the most-anticipated FDA pending approvals expected in 2023 that neurological researchers and clinicians should keep an eye out on.

Natalia Rost, MD, MPH, FAAN, FAHA
Treatment Disparities, Neurologic Complications Clarified by COVID-19 Neurological Research

April 19th 2021

Chloe Hill, MD, MS
Out-of-Pocket Costs Steadily Increasing for Neurologic Care

January 5th 2021

Stuart Peltz, PhD
MOVE-FA Study Initiated for Friedriech’s Ataxia in Children and Young Adults

December 23rd 2020

Gavin Corcoran, MD
Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

December 16th 2020

Video Interviews
Podcasts
Angelman syndrome researcher
©BabyFruity/Shutterstock
©StockLite/Shutterstock

More News

© 2024 MJH Life Sciences

All rights reserved.